Discover how to plan, execute, and optimize your EMPQ to ensure regulatory compliance and protect product integrity. A successful Environmental Monitoring Performance Qualification (EMPQ) is critical to maintaining control of your manufacturing environment. Yet, many organizations underestimate the time, resources, and coordination required to complete the process efficiently.

In this whitepaper, Gillson Sciences Manager of Global Operations, Erin Thane, outlines the essential steps for achieving EMPQ readiness—from understanding regulatory expectations and cleanroom classifications to aligning stakeholders, defining test parameters, and minimizing downtime.

You’ll learn:

• What regulators expect from EMPQ design and documentation
• How to build a realistic EMPQ timeline and minimize disruptions
• Common pitfalls that delay qualification efforts

Gillson Sciences is proud to announce that Tim Bochula, President, has been appointed to serve on one of the United States Pharmacopeial Convention (USP)’s prestigious Expert Committees for the 2025–2030 cycle. This appointment acknowledges Tim’s profound scientific expertise and dedication to advancing global standards for high-quality medicines and ingredients.

USP officially announced the rosters of its 28 Expert Committees on July 16, 2025, selecting over 350 distinguished volunteers from a competitive pool of nearly 5,000 applicants across 128 countries. These committees play a vital role in USP’s mission to improve public health by developing and maintaining rigorous standards for medicines, dietary supplements, and food ingredients used worldwide.

Tim will contribute to USP’s standards-setting process alongside other scientific leaders, FDA liaisons, and global regulators. His committee assignment reflects Gillson Sciences’ growing influence in pharmaceutical innovation and quality assurance. USP standards are recognized in more than 140 countries and published in compendia such as the U.S. Pharmacopeia–National Formulary (USP–NF), the Food Chemicals Codex (FCC), and the Herbal Medicines Compendium (HMC).

“We’re thrilled to see Tim’s expertise recognized at this level,” said Gillson Sciences CEO, Jason Fischer. “His appointment underscores our commitment to scientific rigor and global collaboration in ensuring the safety and efficacy of the products consumers rely on.”

Tim’s participation will help shape the future of pharmaceutical quality, contributing to USP’s efforts to address evolving challenges in medicine development, regulation, and distribution. His appointment also reinforces Gillson Sciences’ dedication to advancing public health through science-driven leadership.

For more information about USP’s Expert Committees and their work, visit USP’s official announcement.

Gillson Sciences is proud to announce its official formation, marking a significant milestone in the evolution of scientific services that support quality, safety, and regulatory excellence across the healthcare ecosystem. Gillson combines deep expertise in laboratory testing, monitoring, and advisory services to empower clients across the pharmaceuticals, biopharma, medical devices, healthcare, and environmental sciences sectors.

Formed in January 2025, Gillson Sciences unites two industry leaders—Azzur Labs (now Gillson Testing) and Micro Measurement Laboratories (MML)—to deliver comprehensive, science-driven solutions across the product lifecycle. With GMP-compliant laboratories in Pennsylvania, Illinois, and California, and field personnel nationwide, Gillson is positioned to serve clients with precision, integrity, and responsiveness.

Jason Fischer has been named CEO, bringing over a decade of leadership experience from UL Solutions, where he spearheaded strategic growth through partnerships and more than 40 acquisitions. His vision for Gillson is clear: “Gillson Sciences represents the opportunity to build a market leader in testing, monitoring, and advisory solutions focused on advancing human health,” said Fischer. “We have a great foundation with our outstanding employees and clients, a motivating mission, and the right partners to deliver on our plan”.

Gillson’s mission is to support clients in developing, sourcing, manufacturing, and commercializing safe and effective products. Its services are considered mission-critical by regulatory bodies, enabling clients to maintain operations and meet stringent compliance demands.

Looking ahead, Gillson will continue to expand its capabilities within the testing, inspection, certification, and compliance (TICC) sector. The company is actively seeking partnerships with organizations that share its commitment to scientific excellence and regulatory integrity.